Navigation Links
Angioslide Closes US$8.6million Series C Financing
Date:6/2/2008

HERZLIYA, Israel, June 2 /PRNewswire/ -- Angioslide, Ltd. today announced the closing of an US$8.6 million Series C financing round. Angioslide is the developer of the unique Angioslide eXtra(TM) angioplasty balloon catheter that provides dual functionality in a single device offering balloon angioplasty with embolic protection. The device has received European CE Mark approval for lower limb use and FDA clearance is expected by end of 2008. The financing will be used to support sales and marketing efforts in the U.S. and Europe as well as for continuous development of expanded market applications. European sales activities shall commence September 2008.

Itochu Corporation, Japan, led this second round of financing with support from Ofer Hi-Tech, Israel and Viola Partners, Israel, who both participated in the previous financing round.

The Angioslide eXtra balloon angioplasty catheter offers balloon angioplasty with embolic particle capture creating a first of its kind device. When performing Angioplasty physicians typically take a two-step approach using both an embolic protection device and a balloon angioplasty catheter. The Angioslide eXtra takes this two-step, two-device process and reduces it to one single instrument, used for one single procedure, with a minimized procedure time and significantly reduced costs.

"After 30 years of balloon angioplasty, this is the first time that a balloon can do more than standard inflation and deflation and the response from the medical community has been remarkable. Imagine a lower limb angioplasty product that functions as both a balloon catheter and an embolic protection device," said Doron Besser, CEO of Angioslide. "With the increasing amount of procedures being performed in the lower limbs and other peripheral regions causing a higher rate of embolic events, it is clear from capitol infusion we have received that the Angioslide eXtra is addressing an unmet need. I can't think of a better qualified investor group to partner with than, Itochu, Ofer Hi-tech and Viola, as we look to FDA approval later this year and initiating European and U.S. sales."

"We are very proud of the first involvement with the Itochu Corporation. The strong management team coupled with an innovative product offering promises to change the landscape of angioplasty and peripheral vascular disease treatment," said Lihu Avitov, Executive Vice President, Ofer Hi-Tech.

About Angioslide, Ltd. Angioslide was founded in 2005 in Herzliya, Israel. They have developed a unique angioplasty balloon catheter that has dual functionality in a single device: balloon angioplasty with embolic protection. The Angioslide eXtra addresses an unmet need for an easy-to-use, efficient and cost-effective embolic protection solution for the peripheral vascular disease market. It is the first device of its kind to seek FDA clearance for use in lower limbs. The device has received European CE Mark approval for lower limb use with FDA clearance expected by end of year 2008 followed by application for renal use. For more information contact Doron Besser at doronb@angioslide.com.

Contact:

Doron Besser

+972-9-955-6500

doronb@angioslide.com


'/>"/>
SOURCE Angioslide Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. 2008 Bank of America Chicago Marathon Registration Closes as Race Reaches 45,000 Participant Capacity
2. Health Plan One Closes $6.5 Million Series A Financing
3. MM2 Group Closes Sale for New Venture in China
4. Haemacure Discloses Positive Results of a preclinical study of its fibrin sealant in adhesion prevention and opens a new opportunity in a market with a significant unmet medical need
5. China Sky One Medical, Inc. Closes Acquisition of Heilongjiang Tianlong Pharmaceutical, Inc.
6. Breathe Technologies, Inc. Closes on $15 Million in Venture Funding Led by Kleiner Perkins Caufield & Byers
7. Alimera Sciences Closes $30 Million in Series C Financing, Increasing Stake in Medidur(TM) FA
8. Allegro Diagnostics Closes $4 Million Round to Develop and Commercialize Lung Cancer Molecular Diagnostics Based on Gene Expression
9. Providence Service Corporation to Report Fourth Quarter 2007 Results on Wednesday, March 12th After the Market Closes
10. DATATRAK Closes Second Multi-Year Enterprise Agreement with European Clinical Trial Sponsor
11. Bacterial toxin closes gate on immune response, Penn researchers discover
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... ... to expand access to affordable hearing aids , increase industry transparency, and ... in the United States. , “For the average consumer, the hearing aid industry ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... sealing company , is proud to announce that many of their franchises have ... customer service. The hard surface restoration franchises received customer recognition through positive reviews ...
(Date:2/8/2016)... ... 08, 2016 , ... The Federal Laboratory Consortium for Technology ... site houses a wealth of federal resources that businesses can leverage to further ... transfer (T2). As a network of over 300 federal laboratories, the FLC’s mission ...
(Date:2/8/2016)... ... ... who has struggled to quit smoking, a man who has struggled with hair loss – ... his problems – and he did. Now Nabat, a serial entrepreneur featured as the October ... to the world and better people's lives. His own experience with nicotine addiction led to ...
(Date:2/8/2016)... ... 2016 , ... The Bell Agency, a full service insurance ... their ongoing community enrichment program. The current campaign fundraises for Angels & Doves, ... being accepted at: http://www.angelsanddoves.com/donate.html . , Angels & Doves was founded in ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)... , Feb. 9, 2016   AllCare Plus Pharmacy ... Commission,s Gold Seal of Approval ® for ... its performance standards. The Gold Seal of Approval ® ... organization,s commitment to providing safe and effective care.  ... Plus Pharmacy underwent a rigorous on-site survey in January ...
(Date:2/9/2016)... Hearing protection devices refer to the barriers ... the inner ear. Hearing protection devices include earplugs, uniform ... recommended for users exposed to noise levels of over ... that are inserted in the ear canal to protect ... more natural sound perception with the help of acoustic ...
(Date:2/9/2016)... The new report "Global Blood Monitoring & Cardiac Monitoring Devices Market ... group reveals that global market for blood monitoring & cardiac monitoring ... to grow to US$ 24,830.1 million by 2019 at a CAGR ... , Europe , Asia-Pacific ... and Africa . The three major factors ...
Breaking Medicine Technology: